Related Experiment Videos

[The frequency of some infections in patients with coronary artery disease]

Insights

This study found that a higher number of infections in individuals is linked to increased coronary artery disease (CAD) risk. While IgE levels were higher in CAD patients, only opisthorchosis showed a direct link to the disease.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Immunology

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • The role of infectious agents in the development of CAD is an area of ongoing research.
  • Previous studies suggest potential links between specific infections and cardiovascular health.

Purpose of the Study:

  • To investigate the association between specific infective and parasite agents and the prevalence of coronary artery disease (CAD).
  • To examine the relationship between immunoglobulin levels (IgM, IgG, IgE) and CAD.
  • To determine if the burden of infection correlates with CAD risk factors.

Main Methods:

  • A random population sample of 389 adults aged 25-64 years was studied.
  • Immune-enzyme assay was used to measure IgM and IgG antibodies against seven agents: Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum, Trichomonas vaginalis, Candida albicans, Opisthorchis felineus, and Giardia lamblia.
  • Immunoglobulin E (IgE) levels were also measured.

Main Results:

  • Individuals with CAD exhibited significantly higher IgE levels compared to controls.
  • The elevated IgE level was not associated with most infections studied, except for Opisthorchis felineus.
  • A higher incidence of certain pathogens was observed in CAD patients.
  • A greater total number of detected infections per individual correlated with a higher frequency of CAD and certain atherosclerotic risk factors.

Conclusions:

  • The overall infectious burden, rather than specific individual infections (barring opisthorchosis), may play a role in the pathogenesis of CAD.
  • Elevated IgE levels in CAD patients warrant further investigation, particularly in relation to parasitic infections.
  • These findings suggest a multifactorial etiology for CAD, potentially involving infectious triggers and immune responses.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...